Basic Parlodel Information

• INN (International Nonproprietary Name): Bromocriptine.
• Brand Names Available In United Kingdom: Parlodel; Parlodel Sandoz; Bromocriptin-ratiopharm; Cycloset (US diabetes formulation noted).
• ATC Code: G02CB01 (Bromocriptine).
• Forms & Dosages: Tablets commonly 2.5 mg; 5 mg tablets exist in some countries but are not universal.
• Manufacturers In United Kingdom: Novartis Pharma / Novartis Sandoz; Ratiopharm; Teva; Zentiva (listed as global suppliers and generics).
• Registration Status In United Kingdom: Not specified.
• OTC / Rx Classification: Rx only (prescription required in nearly all markets).

If you have been prescribed Parlodel (bromocriptine) you need clear guidance on how to use it safely alongside work, travel and family life.

Keep your GP or specialist’s instructions and your NHS prescription record with you.

Avoid driving or operating heavy machinery until you know how Parlodel affects you, especially during dose changes.

Store tablets at room temperature in the original blister and protect them from moisture.

Report serious side effects to the MHRA Yellow Card scheme and tell your pharmacist or GP promptly if you are pregnant, breastfeeding or on several other medicines.

Plan dose times around meals and your commute, and carry a small checklist for dose increases and blood-pressure checks to make titration easier in daily life.

Everyday Use & Best Practices

Morning Vs Evening Dosing

Which dose timing reduces nausea and dizziness is a common worry for new users.

Parlodel is usually started at low doses such as 1.25–2.5 mg and then titrated up as directed by your prescriber.

For hyperprolactinaemia the typical starting single dose is 1.25–2.5 mg once daily or twice daily.

Many patients find that taking the first dose at night reduces initial nausea and dizziness.

Once the medicine is tolerated the morning dose can be moved to daytime if preferred.

If you work shifts or travel, discuss a practical dosing plan with your pharmacist or GP so monitoring can be timed appropriately.

Taking With Or Without Meals

Food can blunt nausea caused by dopamine agonists and is often useful for UK-style breakfasts or evening meals.

If you take Parlodel in the morning try it with a light snack or after breakfast to reduce stomach upset.

For evening doses a small amount of food often helps with tolerability.

If your day includes high-caffeine beverages such as strong tea or coffee, take the tablet at least 30 minutes away from the strongest tea peak to reduce jitteriness.

Check blood pressure while seated and standing during dose escalation because orthostatic hypotension is a recognised risk.

• Timed Dosing Schedule (Example):
• Day 1–3: 1.25 mg at night.
• Day 4–7: 1.25 mg morning and 1.25 mg night if tolerated.
• Week 2 onward: increase in steps to achieve effective maintenance dose as advised by the prescriber.
• BP Checklist:
• Record seated and standing blood pressure each morning during titration.
• Alert GP if systolic BP drops by more than 20 mmHg on standing or you feel dizzy or faint.

Safety Priorities

Who Should Avoid It (MHRA Warnings)

Which medical conditions rule Parlodel out is often the first question at the pharmacy counter.

Absolute contraindications include known hypersensitivity to bromocriptine or other ergot alkaloids.

Do not use Parlodel if you have uncontrolled hypertension.

Current severe psychotic disorders are absolute contraindications because dopamine agonists may worsen psychosis.

Postpartum use is contraindicated where there is pre‑eclampsia, eclampsia or severe cardiovascular risk.

Use with caution and under close monitoring if you have cardiovascular disease, liver or kidney impairment, or a history of psychiatric illness.

Older patients need careful dose selection because of higher risk of hypotension, confusion and falls.

Activities To Limit (Driving, Work Safety)

Driving and operating heavy machinery should be avoided during initiation and after dose increases until you know how Parlodel affects you.

Stop driving and sit down if you experience dizziness, fainting or marked lightheadedness after a dose.

For people working at heights or with heavy equipment, inform your employer and GP while you are starting or changing doses.

• Who Should Notify GP Immediately:
• Anyone with a history of psychosis or severe mental illness before starting treatment.
• Anyone with cardiovascular disease or uncontrolled hypertension.
• Anyone who becomes pregnant or plans pregnancy while on treatment.
• Warning Signs Requiring Urgent Review:

Dosage & Adjustments

General Regimen (NHS Guidance)

NHS practice follows a “start low, titrate slowly” approach to bromocriptine dosing.

For hyperprolactinaemia start at 1.25–2.5 mg once or twice daily and adjust according to prolactin response and tolerability.

Maintenance for hyperprolactinaemia is often up to 7.5 mg per day in divided doses, with a commonly cited maximum of 15 mg per day.

Acromegaly and Parkinson’s regimens use similar cautious escalation but can reach higher maintenance doses under specialist supervision.

Missed-dose advice: take as soon as remembered unless it is close to the next dose; do not double up.

Special Cases (Elderly, Comorbidities)

Older adults should start at the lower end of dosing ranges and titrate more slowly.

Be alert to confusion, sedation and falls in elderly patients when doses are increased.

In hepatic or renal impairment lower starting doses and closer monitoring are advised because formal guidelines are limited.

Children should be treated only under specialist paediatric endocrine or neurology care with no standard dosing for general use.

• Checklist For Dose-Adjustment Triggers:
• Significant drop in standing BP or symptoms of orthostatic hypotension.
• New or worsening nausea, vomiting or persistent gastrointestinal upset.
• New psychiatric symptoms such as severe anxiety, hallucinations or confusion.
• Poor adherence due to dosing frequency — discuss switching options with your specialist.

User Testimonials

Positive Reports From UK Patients

Many UK patients report quick improvement in galactorrhoea and menstrual irregularities at low doses.

Some patients describe normalised prolactin and restored fertility within weeks of starting treatment.

Users often praise the convenience of 2.5 mg tablets and the availability of generics at major pharmacies.

Common Challenges (Patient.info, NHS Forums)

Early nausea, dizziness and repeated blood-pressure checks during titration are commonly reported on Patient.info and NHS threads.

Parkinson’s patients note motor improvement but higher doses can bring about hallucinations in some individuals.

When side effects persist many patients discuss switching to cabergoline because of its longer half-life and often better tolerability.

• Positive Experiences:
• Effective reduction of breast milk leakage and fast prolactin suppression.
• Improved fertility outcomes reported in some cases.
• Problematic Experiences:
• Initial nausea and dizziness leading to work disruption for a few days.
• Frequent BP monitoring required during titration.
• When To Call GP/Pharmacy:
• Persistent vomiting, fainting spells or collapse.
• New or worsening hallucinations or severe mood changes.

Buying Guide

Pharmacy Sources

Parlodel and generics are stocked by major UK pharmacy chains and many online NHS‑accredited pharmacies.

Boots, LloydsPharmacy and some Superdrug branches typically dispense bromocriptine with a prescription.

Generics from Sandoz, Ratiopharm, Teva and Zentiva are commonly available and may be dispensed instead of the branded product.

Always verify an online seller’s General Pharmaceutical Council (GPhC) registration and MHRA-compliant dispensing procedures before ordering.

Price Comparison (NHS Prescription Charge Vs Private)

In England, a prescription usually attracts the NHS prescription charge per item at the point of dispensing.

Prescriptions are free in Scotland, Wales and Northern Ireland, which should be considered when calculating cost.

Private online pharmacies may offer home delivery and price differences between branded Parlodel and generic bromocriptine can be significant.

In our online pharmacy Parlodel is available by prescription, with discreet delivery to the United Kingdom in 5–14 days.

• Checklist For Safe Online Purchase:
• Verify pharmacy registration (GPhC) and a legitimate postal address.
• Ensure a valid prescription is required at ordering.
• Look for MHRA Yellow Card information and a clear privacy policy.
• Check pack size and excipients if you have lactose or other intolerances.

What’s Inside & How It Works

Ingredients Overview

The active ingredient is bromocriptine, typically supplied as 2.5 mg tablets in blister packs.

Excipients vary by manufacturer so check the patient leaflet if you have allergies or intolerances to ingredients such as lactose.

Mechanism Basics Explained Simply

Bromocriptine is a dopamine D2 receptor agonist which suppresses prolactin release from the pituitary.

Reduced prolactin explains the benefits in hyperprolactinaemia such as the resolution of galactorrhoea and restored menstrual function.

Its dopaminergic effect in the central nervous system can improve motor function in Parkinson’s disease.

In acromegaly bromocriptine can reduce growth hormone secretion as part of adjunctive therapy.

The mechanism also explains common side effects: gastrointestinal dopamine receptors can cause nausea and vascular effects can cause hypotension.

• Excipient Cautions:
• Check your leaflet for lactose if you have intolerance.
• Different generics may use different fillers and colouring agents.

Main Indications

Approved Uses (MHRA Listing)

Bromocriptine is approved globally for hyperprolactinaemia, acromegaly and adjunctive use in Parkinson’s disease.

Parlodel tablets are commonly the 2.5 mg formulation used for these indications.

On the NHS cabergoline is often preferred for hyperprolactinaemia because of its longer half-life and often better tolerability, but bromocriptine remains an established option.

Off-Label Uses In UK Clinics

Some research and specialist clinics have explored bromocriptine in metabolic syndrome and investigational roles, but this is not routine NHS prescribing.

Any off‑label use should be managed by a specialist with a clear monitoring plan.

Interaction Warnings

Food Interactions (Alcohol, Tea/Coffee)

Avoid alcohol during initiation or dose increases because it may worsen hypotension and drowsiness.

Space doses away from strong caffeinated drinks to reduce jitteriness and gastrointestinal upset.

Drug Conflicts (MHRA Yellow Card Reports)

Drugs that reduce dopamine action such as many antipsychotics can counteract bromocriptine and may precipitate psychiatric effects.

Combining bromocriptine with antihypertensives can increase the risk of orthostatic hypotension.

Certain ergot alkaloids and interacting antibiotics or antifungals may modify exposure and effects; always provide a full medicines list to your prescriber.

Serious events such as hallucinations and syncopal episodes have been reported and should be submitted to the MHRA Yellow Card scheme.

Latest Evidence & Insights

Key UK & EU Studies 2022–2025

Recent literature has compared bromocriptine with cabergoline, focusing on tolerability and adherence.

Reviews continue to show effective prolactin suppression with bromocriptine but a higher rate of early adverse events versus cabergoline.

Small pilot studies in the UK have explored low-dose bromocriptine for metabolic benefits, but this is not yet part of routine NHS care.

Practical Takeaways For Patients

If side effects occur early, discuss switching to cabergoline with your specialist as cabergoline is often better tolerated.

Expect regular prolactin monitoring and blood-pressure checks during titration.

Specialist-led decisions apply when switching in pregnancy planning, acromegaly or Parkinson’s disease contexts.

• Study Highlights (Author, Year):
• Comparative reviews of bromocriptine versus cabergoline (2022–2024) focusing on tolerability.
• UK pilot metabolic studies of low-dose bromocriptine (2023–2024) with preliminary findings.

Alternative Choices

NHS Prescribing Alternatives With Pros/Cons Checklist

Cabergoline and quinagolide are the main alternatives on the NHS for hyperprolactinaemia.

Cabergoline advantages include less frequent dosing and typically better tolerability.

Quinagolide is another oral option with a different side-effect profile.

• Pros For Cabergoline: Less frequent dosing; often preferred for long-term adherence.
• Cons For Cabergoline: Cost and access in some settings; not always favoured in specific fertility plans.
• When To Consider Switching: Intolerable nausea, symptomatic hypotension or poor adherence.
• Specialist endocrinologists or neurologists generally manage switches, particularly in pregnancy planning or acromegaly.

When To Discuss Switching (GP Vs Specialist)

Simple tolerability issues may be raised with your GP first.

Switching for pregnancy planning, acromegaly or complex Parkinson’s therapy should be discussed with a specialist consultant.

Regulation Snapshot

MHRA Approval & NHS Prescribing Framework

Parlodel (bromocriptine) is MHRA-regulated and is prescription-only across the UK.

Formulary choices may vary between NHS trusts with some preferring cabergoline for cost and tolerability reasons.

Keep prescriber letters when switching brands because excipients and pack formats may differ.

Pharmacovigilance & Reporting (Yellow Card)

Report any new or severe adverse reaction to the MHRA Yellow Card scheme online or via a pharmacist.

Pharmacists routinely counsel on orthostatic precautions and may offer BP checks during titration.

• Regulatory Points:
• Prescription-only medicine regulated by the MHRA.
• Formulary preferences may affect which brand is supplied locally.
• How To Report: Use the MHRA Yellow Card website or ask your pharmacist for assistance in submitting a report.

FAQ Section

Common UK Patient Questions

Q1: Can I get Parlodel on repeat prescription?

A1: Yes for chronic conditions subject to GP or specialist review and monitoring of prolactin and blood pressure.

Q2: Is it safe in pregnancy?

A2: Discuss with your specialist; bromocriptine has historical use in pregnancy decisions but treatment is personalised and requires immediate discussion if pregnancy is planned.

Q3: What if I feel faint after a dose?

A3: Sit or lie down immediately and check your blood pressure.

If collapse occurs or hypotension persists seek urgent medical advice.

Q4: Can I switch brands?

A4: Yes, but inform your prescriber and pharmacist because generic excipients may differ and monitoring instructions should be consistent.

Useful resources: NHS and MHRA patient pages provide official guidance on monitoring and reporting.

Guidelines For Proper Use

UK Pharmacist Counselling Style

Pharmacists should explain starting dose, timing with food, expected side effects and orthostatic precautions at the point of dispensing.

They should check medication lists for potential interactions and advise on Yellow Card reporting for serious adverse events.

Community pharmacists may offer blood-pressure checks during titration and provide an information leaflet with each supply.

NHS Patient Support Advice

Ask your GP or specialist to set up a monitoring plan for prolactin levels and blood pressure.

Keep hospital letters and specialist recommendations for repeat prescriptions and cross-service care.

Practical tips: keep a symptom diary during titration noting nausea, dizziness and sleep changes.

• Pharmacy Counselling Checklist:
• Explain start-low titration and when to seek help.
• Advise on food timing and BP monitoring.
• Provide Yellow Card reporting instructions and an emergency contact plan.

Printable Patient Monitoring Diary Template

Date | Dose Taken | Seated BP | Standing BP | Nausea (Y/N) | Dizziness (Y/N) | Notes.

Delivery Across United Kingdom

Final Notes For Patients

Parlodel (bromocriptine) is an effective dopamine agonist when used as directed for hyperprolactinaemia, acromegaly or adjunctive Parkinson’s therapy.

Start low and go slow to reduce early side effects such as nausea, dizziness and orthostatic hypotension.

Keep a clear record of prescriptions, monitoring results and any side effects to share with your GP or specialist.

Report serious or unexpected reactions to the MHRA Yellow Card scheme and consult your pharmacist for practical tips on tolerability and timing.

If you are unsure about interactions with other medicines, bring a full list to your next appointment.

Switching to alternatives such as cabergoline is an option where tolerability or adherence is an issue and should be discussed with a specialist.